APLNR and neoplasm: These observations are in line with a recent study showing that ECs during tumor angiogenesis can be labeled by a CreERT2 transgene in the Aplnr locus while quiescent blood vessels in the surrounding tissue are not labeled (Zhao et al., 2018).